ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Nov 4, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will be participating in the following investor conferences in November:
Read more at globenewswire.com
